Bladder cancer remains a major global health concern, with primary care physicians playing a vital role in early detection and patient outcomes. In her latest article, Sarah Rose Anderson, Oncology Strategy Lead at Novotech, explores: 🔹 The latest therapeutic breakthroughs (immunotherapy, CAR-T, gene therapy) 🔹 The role of clinical trials in driving innovation 🔹 Global disparities in care access 🔹 Practical strategies for PCPs and researchers Read how innovation, collaboration, and education can reshape the future of bladder cancer management. https://lnkd.in/dSRBmDdv #Oncology #BladderCancer #Novotech
